| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |